Back to Search
Start Over
Prevention of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Therapy: Real-World Examination of the Impede Study
- Source :
- Blood; November 2020, Vol. 136 Issue: Supplement 1 p15-16, 2p
- Publication Year :
- 2020
-
Abstract
- Parnes: Geron: Current equity holder in publicly-traded company; Shire/Takeda: Consultancy, Research Funding; Sigilon: Consultancy; UniQure: Consultancy; I-Mab: Consultancy; Bayer: Consultancy; Sunovion: Consultancy; Genentech: Research Funding.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 136
- Issue :
- Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs54556177
- Full Text :
- https://doi.org/10.1182/blood-2020-140175